
Samantha L. Shterengarts
Examiner (ID: 2, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 4131, 1623, 1626 |
| Total Applications | 2313 |
| Issued Applications | 1786 |
| Pending Applications | 96 |
| Abandoned Applications | 469 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12701980
[patent_doc_number] => 20180125826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 15/725500
[patent_app_country] => US
[patent_app_date] => 2017-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15725500
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/725500 | Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GluN2B receptor modulators | Oct 4, 2017 | Issued |
Array
(
[id] => 13106655
[patent_doc_number] => 10071960
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-09-11
[patent_title] => Enaminone-grafted trithiocarbonate with anticancer and antimicrobial activity
[patent_app_type] => utility
[patent_app_number] => 15/726263
[patent_app_country] => US
[patent_app_date] => 2017-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 3811
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15726263
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/726263 | Enaminone-grafted trithiocarbonate with anticancer and antimicrobial activity | Oct 4, 2017 | Issued |
Array
(
[id] => 12584607
[patent_doc_number] => 20180086698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => SUBSTITUTED 3-HALOALLYLAMINE INHIBITORS OF SSAO AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/725363
[patent_app_country] => US
[patent_app_date] => 2017-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15725363
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/725363 | Substituted 3-haloallylamine inhibitors of SSAO and uses thereof | Oct 4, 2017 | Issued |
Array
(
[id] => 12126401
[patent_doc_number] => 20180009987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'Method of Synthesizing Near IR, Closed Chain Sulfo-Cyanine Dyes'
[patent_app_type] => utility
[patent_app_number] => 15/711256
[patent_app_country] => US
[patent_app_date] => 2017-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9900
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15711256
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/711256 | Method of synthesizing near IR, closed chain sulfo-cyanine dyes | Sep 20, 2017 | Issued |
Array
(
[id] => 18369062
[patent_doc_number] => 11649216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Method for preparing Macitentan and intermediate compound thereof
[patent_app_type] => utility
[patent_app_number] => 16/336504
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7169
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336504
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/336504 | Method for preparing Macitentan and intermediate compound thereof | Sep 19, 2017 | Issued |
Array
(
[id] => 12239903
[patent_doc_number] => 20180072767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'TREHALOSE ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 15/701084
[patent_app_country] => US
[patent_app_date] => 2017-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 23737
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15701084
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/701084 | Trehalose analogues | Sep 10, 2017 | Issued |
Array
(
[id] => 13716925
[patent_doc_number] => 20170369417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => TAK1 Kinase Inhibitors, Compositions, and Uses Related Thereto
[patent_app_type] => utility
[patent_app_number] => 15/694982
[patent_app_country] => US
[patent_app_date] => 2017-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 428
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15694982
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/694982 | TAK1 kinase inhibitors, compositions, and uses related thereto | Sep 3, 2017 | Issued |
Array
(
[id] => 17968187
[patent_doc_number] => 11485701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Insect repellent compounds and compositions, and methods thereof
[patent_app_type] => utility
[patent_app_number] => 15/684770
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 17025
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15684770
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/684770 | Insect repellent compounds and compositions, and methods thereof | Aug 22, 2017 | Issued |
Array
(
[id] => 14003225
[patent_doc_number] => 10220040
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Compounds, compositions and methods useful for cholesterol mobilization
[patent_app_type] => utility
[patent_app_number] => 15/681944
[patent_app_country] => US
[patent_app_date] => 2017-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 21
[patent_no_of_words] => 50800
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15681944
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/681944 | Compounds, compositions and methods useful for cholesterol mobilization | Aug 20, 2017 | Issued |
Array
(
[id] => 14403543
[patent_doc_number] => 20190167615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => METABOLITES FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/323726
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323726
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/323726 | METABOLITES FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE | Aug 9, 2017 | Abandoned |
Array
(
[id] => 15175517
[patent_doc_number] => 20190358350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => METHODS AND COMPOSITIONS FOR NEAR INFRARED FLUORESCENT NANODOTS WITH AGGREGATION-INDUCED EMISSION CHARACTERISTICS
[patent_app_type] => utility
[patent_app_number] => 16/324851
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9221
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324851
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/324851 | Methods and compositions for near infrared fluorescent nanodots with aggregation-induced emission characteristics | Aug 9, 2017 | Issued |
Array
(
[id] => 12057065
[patent_doc_number] => 20170333406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'THERAPEUTIC COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/667227
[patent_app_country] => US
[patent_app_date] => 2017-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 226843
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15667227
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/667227 | THERAPEUTIC COMPOUNDS AND USES THEREOF | Aug 1, 2017 | Abandoned |
Array
(
[id] => 14375061
[patent_doc_number] => 20190161443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => PROCESSES FOR MAKING, AND METHODS OF USING, GLYCOPYRRONIUM COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/320999
[patent_app_country] => US
[patent_app_date] => 2017-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320999
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320999 | Processes for making, and methods of using, glycopyrronium compounds | Jul 31, 2017 | Issued |
Array
(
[id] => 13805051
[patent_doc_number] => 10179787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-15
[patent_title] => Chemokine receptor modulators and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/662861
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93856
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15662861
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/662861 | Chemokine receptor modulators and uses thereof | Jul 27, 2017 | Issued |
Array
(
[id] => 16532066
[patent_doc_number] => 10874641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Methods of treating acute kidney injury
[patent_app_type] => utility
[patent_app_number] => 16/320152
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5170
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320152 | Methods of treating acute kidney injury | Jul 26, 2017 | Issued |
Array
(
[id] => 12813016
[patent_doc_number] => 20180162842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
[patent_app_type] => utility
[patent_app_number] => 15/659926
[patent_app_country] => US
[patent_app_date] => 2017-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15659926
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/659926 | Modulators of ATP-binding cassette transporters | Jul 25, 2017 | Issued |
Array
(
[id] => 16862840
[patent_doc_number] => 11021572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Photosensitive resin composition, cured product of same, interlayer insulating film, surface protective film and electronic component
[patent_app_type] => utility
[patent_app_number] => 16/320889
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10025
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320889 | Photosensitive resin composition, cured product of same, interlayer insulating film, surface protective film and electronic component | Jul 24, 2017 | Issued |
Array
(
[id] => 12029447
[patent_doc_number] => 20170319546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'SALINOSPORAMIDES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/655739
[patent_app_country] => US
[patent_app_date] => 2017-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7773
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15655739
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/655739 | Salinosporamides and methods of use thereof | Jul 19, 2017 | Issued |
Array
(
[id] => 14420071
[patent_doc_number] => 10314821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Crystalline forms of 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide
[patent_app_type] => utility
[patent_app_number] => 15/651385
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 6987
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651385
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/651385 | Crystalline forms of 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide | Jul 16, 2017 | Issued |
Array
(
[id] => 12023602
[patent_doc_number] => 20170313701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'Fused Heterocyclic Compounds as Selective BMP Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/652100
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27753
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15652100
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/652100 | Fused heterocyclic compounds as selective BMP inhibitors | Jul 16, 2017 | Issued |